论文信息 - Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial - 字舞流文

Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

Ying Cheng | Yi-long Wu | Jin-Ji Yang | Zhidong Liu | Xue-Ning Yang | P. Yu | Songtao Xu | Cheng Huang | W. Mao | R. Yin | S. Ren | Fan Yang | Qun Wang | Ke-Neng Chen | Buhai Wang | Chun Chen | Shun Xu | Hong-Hong Yan | Wenhui Zhong | Lin Wu | Yu-cheng Wei | S. Liu | Yongyu Liu | Xiao-fei Li | Jian Li | Shi-dong Xu | Lunxu Liu | Haining Ma | Qing Zhou | Songtao Xu | W. Mao | Hong-Hong Yan